Anixa Biosciences (ANIX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.78, +4.51% vs the prior close of $2.66.
- Volume 223.30K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ANIX jumps 4.5% to $2.78. Closed at $2.78, +4.51% vs the prior close of $2.66. Day range $2.63–$2.79, opened at $2.66.
ANIX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ANIX jumps 4.5% to $2.78
- Closed at $2.78, +4.51% vs the prior close of $2.66. Day range $2.63–$2.79, opened at $2.66.
- Volume was 223.30K shares, 0.7x its 50-day average of 302.41K.
- Price is -9.4% vs its 50-day average ($3.07) and -6.8% vs its 200-day average ($2.98).
- 52-week range $2.32–$5.46; today's close sits at 15% of that range, 49.1% below the 52-week high.
Oct 14, 2026 — ANIX dips 0.4% to $2.66, 6 down days in a row
- Closed at $2.66, -0.37% vs the prior close of $2.67. Day range $2.63–$2.82, opened at $2.75.
- Volume was 228.40K shares, 0.8x its 50-day average of 301.74K.
- Price is -13.6% vs its 50-day average ($3.08) and -10.9% vs its 200-day average ($2.98).
- 52-week range $2.32–$5.46; today's close sits at 11% of that range, 51.3% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — ANIX slides 6.0% to $2.67, 5 down days in a row
- Closed at $2.67, -5.99% vs the prior close of $2.84. Day range $2.66–$2.84, opened at $2.84.
- Volume was 175.40K shares, 0.6x its 50-day average of 301.22K — lighter than usual.
- Price is -13.7% vs its 50-day average ($3.09) and -10.6% vs its 200-day average ($2.99).
- 52-week range $2.32–$5.46; today's close sits at 11% of that range, 51.1% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — ANIX dips 2.1% to $2.84, 4 down days in a row
- Closed at $2.84, -2.07% vs the prior close of $2.90. Day range $2.83–$2.92, opened at $2.90.
- Volume was 97.70K shares, 0.3x its 50-day average of 302.84K — lighter than usual.
- Price is -8.7% vs its 50-day average ($3.11) and -5.1% vs its 200-day average ($2.99).
- 52-week range $2.32–$5.46; today's close sits at 17% of that range, 48.0% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — ANIX dips 0.3% to $2.90, 3 down days in a row
- Closed at $2.90, -0.34% vs the prior close of $2.91. Day range $2.86–$2.96, opened at $2.93.
- Volume was 217.90K shares, 0.7x its 50-day average of 300.98K.
- Price is -7.1% vs its 50-day average ($3.12) and -3.1% vs its 200-day average ($2.99).
- 52-week range $2.32–$5.46; today's close sits at 18% of that range, 46.9% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — ANIX dips 1.4% to $2.91
- Closed at $2.91, -1.36% vs the prior close of $2.95. Day range $2.86–$2.93, opened at $2.93.
- Volume was 259.60K shares, 0.9x its 50-day average of 299.18K.
- Price is -7.1% vs its 50-day average ($3.13) and -2.9% vs its 200-day average ($3.00).
- 52-week range $2.32–$5.46; today's close sits at 19% of that range, 46.7% below the 52-week high.
Oct 7, 2026 — ANIX dips 2.3% to $2.95
- Closed at $2.95, -2.32% vs the prior close of $3.02. Day range $2.93–$3.06, opened at $3.01.
- Volume was 245.20K shares, 0.8x its 50-day average of 300.49K.
- Price is -6.2% vs its 50-day average ($3.15) and -1.6% vs its 200-day average ($3.00).
- 52-week range $2.32–$5.46; today's close sits at 20% of that range, 46.0% below the 52-week high.
Oct 6, 2026 — ANIX rises 2.4% to $3.02
- Closed at $3.02, +2.37% vs the prior close of $2.95. Day range $2.87–$3.11, opened at $2.95.
- Volume was 344.90K shares, 1.1x its 50-day average of 302.25K.
- Price is -4.3% vs its 50-day average ($3.16) and +0.7% vs its 200-day average ($3.00).
- 52-week range $2.32–$5.46; today's close sits at 22% of that range, 44.7% below the 52-week high.
Oct 5, 2026 — ANIX ends flat (+0.0%) to $2.95
- Closed at $2.95, +0.00% vs the prior close of $2.95. Day range $2.88–$2.99, opened at $2.98.
- Volume was 369.30K shares, 1.2x its 50-day average of 301.65K.
- Price is -6.8% vs its 50-day average ($3.17) and -1.7% vs its 200-day average ($3.00).
- 52-week range $2.32–$5.46; today's close sits at 20% of that range, 46.0% below the 52-week high.
Oct 2, 2026 — ANIX jumps 6.5% to $2.95
- Closed at $2.95, +6.50% vs the prior close of $2.77. Day range $2.77–$2.95, opened at $2.83.
- Volume was 433.30K shares, 1.4x its 50-day average of 299.47K.
- Price is -7.3% vs its 50-day average ($3.18) and -1.8% vs its 200-day average ($3.00).
- 52-week range $2.32–$5.46; today's close sits at 20% of that range, 46.0% below the 52-week high.
ANIX latest news & SEC filings
Every SEC filing by or about ANIX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Catelani Michael bought 5,500 shares at $2.84 (≈$15.62K) on Sep 30, 2026; now holds 50,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kumar Amit bought 7,000 shares at $2.78 (≈$19.46K) on Sep 24, 2026; now holds 672,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baskies Arnold M bought 5,000 shares at $2.76 (≈$13.80K) on Sep 24, 2026; now holds 140,572
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Titterton Lewis H Jr bought 49,036 shares at $2.69 (≈$131.91K) on Sep 23, 2026; now holds 1,046,003
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kumar Amit bought 3,000 shares at $2.75 (≈$8.25K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Titterton Lewis H Jr bought 10,000 shares at $2.73 (≈$27.30K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 31, 2026:
- Net income: -$2.61M (prior year -$2.26M) (loss widened vs Jul 31, 2025)
- Diluted EPS: -$0.08 (prior year -$0.07) (loss widened vs Jul 31, 2025)
Things to know before you trade ANIX
- How much it moves: over the last 20 sessions the average daily move was 2.27% (largest 6.5%).
- Liquidity: about 301.91K shares (≈$839.31K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.78 vs a range of $2.32–$5.46 (15% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 18 open-market buys, 0 sales; latest: Michael Catelani bought 5,500 shares on Sep 30, 2026.
- Latest filings: 10-Q Sep 9, 2026; 10-Q Jun 10, 2026; 8-K Mar 11, 2026.
- Share count: 34.76M shares outstanding (Sep 9, 2026), +5.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ANIX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.66 | 2.79 | 2.63 | 2.78 | 223.30K |
| Oct 14, 2026 | 2.75 | 2.82 | 2.63 | 2.66 | 228.40K |
| Oct 13, 2026 | 2.84 | 2.84 | 2.66 | 2.67 | 175.40K |
| Oct 12, 2026 | 2.90 | 2.92 | 2.83 | 2.84 | 97.70K |
| Oct 9, 2026 | 2.93 | 2.96 | 2.86 | 2.90 | 217.90K |
| Oct 8, 2026 | 2.93 | 2.93 | 2.86 | 2.91 | 259.60K |
| Oct 7, 2026 | 3.01 | 3.06 | 2.93 | 2.95 | 245.20K |
| Oct 6, 2026 | 2.95 | 3.11 | 2.87 | 3.02 | 344.90K |
| Oct 5, 2026 | 2.98 | 2.99 | 2.88 | 2.95 | 369.30K |
| Oct 2, 2026 | 2.83 | 2.95 | 2.77 | 2.95 | 433.30K |
| Oct 1, 2026 | 2.93 | 2.93 | 2.74 | 2.77 | 290.40K |
| Sep 30, 2026 | 2.85 | 2.95 | 2.81 | 2.93 | 428.90K |
| Sep 29, 2026 | 2.79 | 2.85 | 2.72 | 2.85 | 183.20K |
| Sep 28, 2026 | 2.78 | 2.83 | 2.70 | 2.79 | 305.50K |
| Sep 25, 2026 | 2.85 | 2.87 | 2.69 | 2.78 | 360.80K |
| Sep 24, 2026 | 2.74 | 2.81 | 2.72 | 2.78 | 257.70K |
| Sep 23, 2026 | 2.77 | 2.81 | 2.62 | 2.75 | 391.10K |
| Sep 22, 2026 | 2.73 | 2.79 | 2.68 | 2.79 | 434.10K |
| Sep 21, 2026 | 2.82 | 2.82 | 2.66 | 2.70 | 476.30K |
| Sep 18, 2026 | 2.78 | 2.79 | 2.69 | 2.77 | 315.20K |
About Anixa Biosciences
Anixa Biosciences (ANIX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN JOSE, CA. State of incorporation: DE. Fiscal year ends October 31. SEC CIK 715446.
ANIX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Arnold M Baskies | Director | Sep 28, 2026 |
| Emily Gottschalk | Director | Jan 6, 2026 |
| Amit Kumar | Chief Executive Officer | Sep 28, 2026 |
| Lewis H Jr Titterton | Director | Sep 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Catelani | President, COO, & CFO | Sep 30, 2026 |
| Amit Kumar | Chief Executive Officer | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 30, 2026 | Michael Catelani | Buy | 5,500 | $2.84 |
| Sep 24, 2026 | Amit Kumar | Buy | 7,000 | $2.78 |
| Sep 24, 2026 | Arnold M Baskies | Buy | 5,000 | $2.76 |
| Sep 23, 2026 | Lewis H Jr Titterton | Buy | 49,036 | $2.69 |
| Sep 10, 2026 | Amit Kumar | Buy | 3,000 | $2.75 |
| Sep 10, 2026 | Lewis H Jr Titterton | Buy | 10,000 | $2.73 |
| Sep 10, 2026 | Amit Kumar | Buy | 5,000 | $2.76 |
| Jul 31, 2026 | Amit Kumar | Buy | 5,000 | $3.47 |
| Jul 27, 2026 | Amit Kumar | Buy | 5,000 | $3.44 |
| Jul 27, 2026 | Amit Kumar | Buy | 3,188 | $3.37 |
| Jul 24, 2026 | Amit Kumar | Buy | 3,000 | $3.73 |
| Jul 20, 2026 | Amit Kumar | Buy | 5,000 | $3.46 |
| Jul 20, 2026 | Lewis H Jr Titterton | Buy | 12,000 | $3.47 |
| Jul 15, 2026 | Lewis H Jr Titterton | Buy | 2,797 | $3.28 |
| Jul 10, 2026 | Amit Kumar | Buy | 5,000 | $3.04 |
ANIX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Oct 31, 2025 | — | $-10.93M | -0.34 | $-7.17M |
| Oct 31, 2024 | — | $-12.55M | -0.39 | $-7.33M |
| Oct 31, 2023 | $210.00K | $-9.81M | -0.32 | $-6.21M |
| Oct 31, 2022 | — | $-13.60M | 0.45 | $-6.49M |
| Oct 31, 2021 | $512.00K | $-12.95M | — | $-4.94M |
Latest balance sheet: total assets $15.07M, total liabilities $1.87M, cash $1.40M (as of Jul 31, 2026).
ANIX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ANIX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.